Literature DB >> 17213291

FcRL6, a new ITIM-bearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection.

Timothy J Wilson1, Rachel M Presti, Ilaria Tassi, Edgar T Overton, Marina Cella, Marco Colonna.   

Abstract

Fc receptor-like proteins (FcRLs) are a growing family of molecules homologous to FcgammaRI. Whereas all 7 previously reported Fc receptor homologs are expressed by B cells, here we report a new receptor, FcRL6, that is expressed by cytolytic cells including natural killer (NK) cells and effector and effector-memory CD8(+) T cells. FcRL6 contains a novel cytoplasmic cysteine-rich motif and recruits SHP-2 through a phosphorylated ITIM, indicating a potential signaling function in effector lymphocytes. In vitro, FcRL6 does not greatly influence NK-cell or CD8(+) T-cell-mediated cytotoxicity and has minimal impact on cytokine secretion. However, FcRL6 expression among T lymphocytes is greatly expanded in human immunodeficiency virus type 1 (HIV-1)-infected individuals, and includes not only effector and effector-memory CD8(+) T cells but also populations of CD4(+) T cells. Expansion of FcRL6-positive lymphocytes is not related to viral load, but is indicative of the dysregulated expansion of terminally differentiated effector lymphocyte populations in response to chronic HIV-1 infection and may serve as an important marker for chronic immune activation and for tracking the generation of effector cells following immune stimulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17213291     DOI: 10.1182/blood-2006-06-030023

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement.

Authors:  Douglas B Johnson; Mellissa J Nixon; Yu Wang; Daniel Y Wang; Emily Castellanos; Monica V Estrada; Paula I Ericsson-Gonzalez; Candace H Cote; Roberto Salgado; Violeta Sanchez; Phillip T Dean; Susan R Opalenik; Daniel M Schreeder; David L Rimm; Ju Young Kim; Jennifer Bordeaux; Sherene Loi; Leora Horn; Melinda E Sanders; P Brent Ferrell; Yaomin Xu; Jeffrey A Sosman; Randall S Davis; Justin M Balko
Journal:  JCI Insight       Date:  2018-12-20

Review 2.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

3.  Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG.

Authors:  Timothy J Wilson; Anja Fuchs; Marco Colonna
Journal:  J Immunol       Date:  2012-04-09       Impact factor: 5.422

4.  Cutting edge: FcR-like 6 is an MHC class II receptor.

Authors:  Daniel M Schreeder; John P Cannon; Jiongru Wu; Ran Li; Mikhail A Shakhmatov; Randall S Davis
Journal:  J Immunol       Date:  2010-06-02       Impact factor: 5.422

5.  FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia.

Authors:  Daniel M Schreeder; Jicun Pan; Fu Jun Li; Eric Vivier; Randall S Davis
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

6.  Loss and dysfunction of Vδ2⁺ γδ T cells are associated with clinical tolerance to malaria.

Authors:  Prasanna Jagannathan; Charlie C Kim; Bryan Greenhouse; Felistas Nankya; Katherine Bowen; Ijeoma Eccles-James; Mary K Muhindo; Emmanuel Arinaitwe; Jordan W Tappero; Moses R Kamya; Grant Dorsey; Margaret E Feeney
Journal:  Sci Transl Med       Date:  2014-08-27       Impact factor: 17.956

7.  Whole transcriptome profiling reveals major cell types in the cellular immune response against acute and chronic active Epstein-Barr virus infection.

Authors:  Huaqing Zhong; Xinran Hu; Andrew B Janowski; Gregory A Storch; Liyun Su; Lingfeng Cao; Jinsheng Yu; Jin Xu
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

8.  Prognostic significance of Fc receptor-like 1 in patients with chronic lymphocytic leukemia, hairy cell leukemia, and various B-cell non-Hodgkin's lymphoma.

Authors:  Zahra Yousefi; Nahid Eskandari
Journal:  Leuk Res Rep       Date:  2019-08-14

9.  The Xenopus FcR family demonstrates continually high diversification of paired receptors in vertebrate evolution.

Authors:  Sergey V Guselnikov; Thaminda Ramanayake; Aleksandra Y Erilova; Ludmila V Mechetina; Alexander M Najakshin; Jacques Robert; Alexander V Taranin
Journal:  BMC Evol Biol       Date:  2008-05-16       Impact factor: 3.260

10.  Fc Receptor-Like Proteins in Pathophysiology of B-cell Disorder.

Authors:  Mollie Capone; John Matthew Bryant; Natalie Sutkowski; Azizul Haque
Journal:  J Clin Cell Immunol       Date:  2016-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.